摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

disodium;(2R)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate

中文名称
——
中文别名
——
英文名称
disodium;(2R)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate
英文别名
——
disodium;(2R)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate化学式
CAS
——
化学式
C20H19N5Na2O6
mdl
——
分子量
471.4
InChiKey
NYDXNILOWQXUOF-FFXKMJQXSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -8.0
  • 重原子数:
    33
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    193
  • 氢给体数:
    4
  • 氢受体数:
    6

ADMET

毒理性
  • 肝毒性
培美曲塞治疗与血清酶平低至中度升高有关,但这些通常较轻、短暂,且不伴有症状或黄疸。血清ALT或AST升高超过5倍ULN的患者占1%至6%,但通常病程自限,很少需要调整剂量或停药。没有报告因培美曲塞引起的临床明显的急性肝损伤病例。此外,培美曲塞尚未与 sinusoidal obSTruction syndrome (门脉高压症)或乙型肝炎的再激活有关联,但培美曲塞在高剂量用于肿瘤性疾病或骨髓移植的预处理方案中很少使用,而这些情况下其他肿瘤药物常与这些并发症有关。
Pemetrexed therapy is associated with a low-to-moderate rate of serum enzyme elevations, but these are generally mild, transient and without accompanying symptoms or jaundice. Serum ALT or AST elevations above 5 times ULN occur in 1% to 6% of patients, but are usually self-limited in course and rarely require dose modification or discontinuation. No instances of clinically apparent acute liver injury attributed to pemetrexed have been reported. In addition, pemetrexed has not been linked to sinusoidal obstruction syndrome or to reactivation of hepatitis B, but it is rarely used in high doses in neoplastic disease or in conditioning regimens for bone marrow transplantation, situations in which other neoplastic agents are commonly associated with these complications.
来源:LiverTox

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] AZOLE ANALOGUES AND METHODS OF USE THEREOF<br/>[FR] ANALOGUES DE COMPOSÉ DE TYPE AZOLE ET LEURS MÉTHODES D'UTILISATION
    申请人:UNIV CONNECTICUT
    公开号:WO2019040363A1
    公开(公告)日:2019-02-28
    Disclosed herein are analogues of itraconazole that are both angiogenesis and hedgehog signaling pathway inhibitors, formulations thereof, including lipsome formulations thereof. The compounds are expected to be useful in the treatment of cell proliferation disorders such as cancer, particularly cancers that are dependent upon the hedgehog signaling pathway such as basal cell carcinoma and medulloblastoma.
    本文披露了伊曲康唑的类似物,既是血管生成抑制剂,又是刺猬信号通路抑制剂,以及包括脂质体制剂在内的配方。这些化合物预计可用于治疗细胞增殖障碍,如癌症,特别是依赖于刺猬信号通路的癌症,如基底细胞癌和髓母细胞瘤。
  • Process for Preparing Pemetrexed Disodium and Its Intermediate, 4-(4-Carbomethoxyphenyl) Butanal
    申请人:Li Jinliang
    公开号:US20110124861A1
    公开(公告)日:2011-05-26
    The present invention provides a process for preparing pemetrexed disodium and its intermediate, 4-(4-carbomethoxyphenyl)butanal. The process for preparing the intermediate comprises the following steps: condensing methyl 4-bromobenzoate with 3-buten-1-ol; extracting with an organic solvent during the work-up; adding silica gel to decolorize; and evaporating the organic solvent to give 4-(4-carbomethoxyphenyl)butanal. The product obtained by the present process, with a yield of higher than 80%, and a purity measured by GC of higher than 95%, may be directly used in the next bromination reaction for synthesizing pemetrexed disodium without purification. The present process is suitable for industrial production, as the operation is simple and the reagents used are cheap and readily available.
    本发明提供了一种制备培美曲塞及其中间体4-(4-羧甲氧基苯基)丁醛的方法。制备中间体的过程包括以下步骤:将甲基4-溴苯酸酯与3-丁烯-1-醇缩合;在工艺中进行有机溶剂萃取;加入硅胶脱色;蒸发有机溶剂得到4-(4-羧甲氧基苯基)丁醛。本工艺获得的产物收率高于80%,通过GC测得的纯度高于95%,可直接用于下一步化反应合成培美曲塞而无需纯化。本工艺适用于工业生产,因其操作简单,所使用的试剂便宜且易得。
  • PROCESSES FOR PREPARING PEMETREXED
    申请人:Kadaboina Rajasekhar
    公开号:US20130165654A1
    公开(公告)日:2013-06-27
    The present invention relates to pemetrexed disodium substantially free from specific process-related impurities, and processes for the preparation thereof.
    本发明涉及到基本没有特定工艺相关杂质的双培美曲塞,以及其制备方法。
  • Process for preparing pemetrexed disodium and its intermediate, 4-(4-carbomethoxyphenyl) butanal
    申请人:Li Jinliang
    公开号:US08507716B2
    公开(公告)日:2013-08-13
    The present invention provides a process for preparing pemetrexed disodium and its intermediate, 4-(4-carbomethoxyphenyl)butanal. The process for preparing the intermediate comprises the following steps: condensing methyl 4-bromobenzoate with 3-buten-1-ol; extracting with an organic solvent during the work-up; adding silica gel to decolorize; and evaporating the organic solvent to give 4-(4-carbomethoxyphenyl)butanal. The product obtained by the present process, with a yield of higher than 80%, and a purity measured by GC of higher than 95%, may be directly used in the next bromination reaction for synthesizing pemetrexed disodium without purification. The present process is suitable for industrial production, as the operation is simple and the reagents used are cheap and readily available.
    本发明提供了一种制备培美曲塞及其中间体4-(4-羧甲氧基苯基)丁醛的方法。制备中间体的过程包括以下步骤:将甲基4-溴苯酸酯与3-丁烯-1-醇缩合;在工作步骤中使用有机溶剂进行提取;加入硅胶进行脱色;蒸发有机溶剂以得到4-(4-羧甲氧基苯基)丁醛。本方法得到的产物收率高于80%,通过气相色谱测得的纯度高于95%,可以直接用于下一步致反应合成培美曲塞而无需纯化。本方法适用于工业生产,因为操作简单,所用试剂便宜且易得。
  • Crystalline form of pemetrexed disodium
    申请人:Albrecht Uwe Jens
    公开号:US09174991B2
    公开(公告)日:2015-11-03
    The present invention relates to a new polymorphic or crystalline form of Pemetrexed Disodium, processes for its preparation and its use, in particular for the preparation of medicaments.
    本发明涉及一种Pemetrexed Disodium的新多晶形或晶型,其制备过程及其用途,特别是用于制备药物。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸